Clindap-t label

Clindap-t

Clindap-t Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

There is currently no usage information available for this product. We apologize for any inconvenience.

History

There is currently no drug history available for this drug.

Other Information

CLINDAP-T®, as dispensed, is comprised of 0.15 g of Adapalene USP and 0.5 g of Clindamycin Phosphate USP for dermatological use.1 CLINDAP-T® also contains a Cream Base containing purified water, white petrolatum, sorbitol solution, cetearyl alcohol, propylene glycol, ceteareth-20, simethicone, glyceryl monostearate, polyethylene glycol monostearate, sorbic acid and BHT. When mixed as instructed, the final product provides a homogeneous cream mixture containing Adapalene and Clindamycin Phosphate comparable to the active ingredients (Differin® 0.3% and Cleocin T® 1%) contained in CLINDAP-T®. 2

1
Certificate of analysis on file
2
This product is not manufactured by Galderma Laboratories, L.P., manufacturer of Differin®, or by Pfizer, Inc., manufacturer of Cleocin T®.

Clindap-t Manufacturers

  • Accumix Pharmaceuticals
    Clindap-t | Accumix Pharmaceuticals
    No Recall

    Clindap-t | Accumix Pharmaceuticals

    Clindap-t | Accumix Pharmaceuticals

    The pharmacist must mix contents of each container with appropriate amount of Cream Base yielding a final volume of 50 grams at the time of dispensing. Pharmacist may utilize appropriate diluents if needed from the respective active component Material Safety Data Sheet only. For dermatological use only. This product should not be administered orally.